These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 23332990
1. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, Tarallo M, Finkelstein FO, Kimmel PL, FHN Trials Group. Am J Kidney Dis; 2013 May; 61(5):748-58. PubMed ID: 23332990 [Abstract] [Full Text] [Related]
2. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS, FHN Trial Group. Am J Kidney Dis; 2011 Jan; 57(1):90-100. PubMed ID: 21122961 [Abstract] [Full Text] [Related]
3. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Frequent Hemodialysis Network Trial Group. Clin J Am Soc Nephrol; 2012 May; 7(5):782-94. PubMed ID: 22422538 [Abstract] [Full Text] [Related]
5. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, Kliger AS, Larive B, Lindsay RM, Pierratos A, Unruh M, Chertow GM, Frequent Hemodialysis Network Trial Investigators. Kidney Int; 2017 Mar; 91(3):746-754. PubMed ID: 28094031 [Abstract] [Full Text] [Related]
6. In-center hemodialysis six times per week versus three times per week. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. N Engl J Med; 2010 Dec 09; 363(24):2287-300. PubMed ID: 21091062 [Abstract] [Full Text] [Related]
8. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S, Frequent Hemodialysis Network (FHN) Trial Group. Circ Cardiovasc Imaging; 2012 Mar 09; 5(2):251-61. PubMed ID: 22360996 [Abstract] [Full Text] [Related]
9. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ. JAMA; 2007 Sep 19; 298(11):1291-9. PubMed ID: 17878421 [Abstract] [Full Text] [Related]
10. Solute clearances and fluid removal in the frequent hemodialysis network trials. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M, Frequent Hemodialysis Network Study Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Am J Kidney Dis; 2009 May 19; 53(5):835-44. PubMed ID: 19339093 [Abstract] [Full Text] [Related]
11. Intensive Hemodialysis and Health-Related Quality of Life. Kraus MA, Fluck RJ, Weinhandl ED, Kansal S, Copland M, Komenda P, Finkelstein FO. Am J Kidney Dis; 2016 Nov 19; 68(5S1):S33-S42. PubMed ID: 27772641 [Abstract] [Full Text] [Related]
12. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, Mehta RL, Kliger AS, Stokes JB, Frequent Hemodialysis Network (FHN) Trial Group. Am J Kidney Dis; 2013 Feb 19; 61(2):228-37. PubMed ID: 23149295 [Abstract] [Full Text] [Related]
18. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials. Chan CT, Kaysen GA, Beck GJ, Li M, Lo JC, Rocco MV, Kliger AS, FHN Trials. Hemodial Int; 2020 Apr 22; 24(2):162-174. PubMed ID: 31826326 [Abstract] [Full Text] [Related]